Showing results (291-300 of 314) with videos related to

Sort By:
Pageof 32
Biochimica Et Biophysica Acta|April 16, 1998
Structure and expression of the human ubiquitin fusion-degradation gene (UFD1L)G Novelli, A Mari, F Amati, et al.
Pediatric Pulmonology|November 16, 2022
The association between pre-existing asthma and reduced risk of death among children and adolescents hospitalized with COVID-19 in BrazilMaria C L Oliveira, Enrico A Colosimo, Mariana A Vasconcelos, et al.
Jornal De Pediatria|July 1, 1997
[Fetal hydronephrosis: postnatal management and follow up]E A de Oliveira, A C Cabral, H V Leite, et al.
Peerj. Computer Science|June 26, 2025
Comparative performance of twelve machine learning models in predicting COVID-19 mortality risk in children: a population-based retrospective cohort study in BrazilAdriano Lages Dos Santos, Maria Christina L Oliveira, Enrico A Colosimo, et al.
American Journal of Human Genetics|April 1, 1996
Human homologue sequences to the Drosophila dishevelled segment-polarity gene are deleted in the DiGeorge syndromeA Pizzuti, G Novelli, A Mari, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 25, 2014
A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary programDebora C Cerqueira, Cristina M Soares, Vanessa R Silva, et al.
Pediatric Nephrology (Berlin, Germany)|June 19, 2008
Clinical outcome of children with chronic kidney disease in a pre-dialysis interdisciplinary programCristina M Bouissou Soares, José Silvério S Diniz, Eleonora M Lima, et al.
Nephrology (Carlton, Vic.)|April 10, 2009
Independent risk factors for renal damage in a series of primary vesicoureteral reflux: a multivariate analysisJose Maria P Silva, Jose Silverio S Diniz, Eleonora M Lima, et al.
World Journal of Pediatrics : WJP|March 14, 2023
Effectiveness of BNT162b2 and CoronaVac vaccines against omicron in children aged 5 to 11 yearsEduardo A Oliveira, Maria Christina L Oliveira, Ana Cristina Simões E Silva, et al.
The Journal of Pediatrics|October 1, 2022
Vaccine Effectiveness against SARS-CoV-2 Variants in Adolescents from 15 to 90 Days after Second Dose: A Population-Based Test-Negative Case-Control StudyEduardo A Oliveira, Maria Christina L Oliveira, Enrico A Colosimo, et al.
Pageof 32